These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 8299710)
1. Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide. De Rosa G; Testa A; Liberale I; Pirronti T; Granone P; Picciocchi A Exp Clin Endocrinol; 1993; 101(5):319-25. PubMed ID: 8299710 [TBL] [Abstract][Full Text] [Related]
2. Pneumocystis carinii pneumonia associated with a rapid reduction of cortisol level in a patient with ectopic ACTH syndrome treated by octreotide and ketoconazole. Kim DS; Park SK; Choi WH; Kim TW; Choi YY; Jeon SC; Ryu JS Exp Clin Endocrinol Diabetes; 2000; 108(2):146-50. PubMed ID: 10826524 [TBL] [Abstract][Full Text] [Related]
3. Suppression of ectopic adrenocorticotropin secretion by the long-acting somatostatin analog octreotide. Bertagna X; Favrod-Coune C; Escourolle H; Beuzeboc P; Christoforov B; Girard F; Luton JP J Clin Endocrinol Metab; 1989 May; 68(5):988-91. PubMed ID: 2565915 [TBL] [Abstract][Full Text] [Related]
4. Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumours. Cheung NW; Boyages SC Clin Endocrinol (Oxf); 1992 Apr; 36(4):361-7. PubMed ID: 1424169 [TBL] [Abstract][Full Text] [Related]
5. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion. Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178 [TBL] [Abstract][Full Text] [Related]
6. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease. Acebes JJ; Martino J; Masuet C; Montanya E; Soler J Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. Phlipponneau M; Nocaudie M; Epelbaum J; De Keyzer Y; Lalau JD; Marchandise X; Bertagna X J Clin Endocrinol Metab; 1994 Jan; 78(1):20-4. PubMed ID: 7904613 [TBL] [Abstract][Full Text] [Related]
8. Androgen secretion in ectopic ACTH syndrome and in Cushing's disease: modifications before and after surgery. Barbetta L; Dall'Asta C; Re T; Colombo P; Travaglini P; Ambrosi B Horm Metab Res; 2001 Oct; 33(10):596-601. PubMed ID: 11607879 [TBL] [Abstract][Full Text] [Related]
9. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M; Elias LL; Elias PC; Moreira AC Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [TBL] [Abstract][Full Text] [Related]
10. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808 [TBL] [Abstract][Full Text] [Related]
11. Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism. Vignati F; Loli P J Clin Endocrinol Metab; 1996 Aug; 81(8):2885-90. PubMed ID: 8768846 [TBL] [Abstract][Full Text] [Related]
12. Octreotide and ectopic Cushing's syndrome--a commentary. James RA Clin Endocrinol (Oxf); 1998 Oct; 49(4):419-20. PubMed ID: 9876337 [No Abstract] [Full Text] [Related]
13. Octreotide exerts different effects in vivo and in vitro in Cushing's disease. Stalla GK; Brockmeier SJ; Renner U; Newton C; Buchfelder M; Stalla J; Müller OA Eur J Endocrinol; 1994 Feb; 130(2):125-31. PubMed ID: 8130885 [TBL] [Abstract][Full Text] [Related]
14. Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome. Woodhouse NJ; Dagogo-Jack S; Ahmed M; Judzewitsch R Am J Med; 1993 Sep; 95(3):305-8. PubMed ID: 8396322 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Cushing's syndrome with the long-acting somatostatin analogue SMS 201-995 (sandostatin). Invitti C; de Martin M; Brunani A; Piolini M; Cavagnini F Clin Endocrinol (Oxf); 1990 Mar; 32(3):275-81. PubMed ID: 2160871 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogue (SMS 201-995) decreases plasma levels of corticotropin (ACTH) and corticotropin-releasing hormone in a patient with ectopic ACTH-producing tumors. Suzuki S; Hashizume K; Kobayashi M; Ichikawa K; Nishii Y; Yokokawa N; Aizawa T; Yamada T; Kameya T Endocrinol Jpn; 1990 Dec; 37(6):923-32. PubMed ID: 1983217 [TBL] [Abstract][Full Text] [Related]
17. Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in two cases of small cell lung carcinoma. Rieu M; Rosilio M; Richard A; Vannetzel JM; Kuhn JM Horm Res; 1993; 39(5-6):207-12. PubMed ID: 8314205 [TBL] [Abstract][Full Text] [Related]
18. Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide. Van den Bruel A; Bex M; Van Dorpe J; Heyns W; Bouillon R Clin Endocrinol (Oxf); 1998 Oct; 49(4):541-6. PubMed ID: 9876354 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous adrenocorticotropic hormone (ACTH) normalisation due to tumour regression induced by metyrapone in a patient with ectopic ACTH syndrome: case report and literature review. Iwayama H; Hirase S; Nomura Y; Ito T; Morita H; Otake K; Okumura A; Takagi J BMC Endocr Disord; 2018 Mar; 18(1):19. PubMed ID: 29587720 [TBL] [Abstract][Full Text] [Related]
20. Lung carcinoid with Cushing's syndrome: control of serum ACTH and cortisol levels using SMS 201-995 (sandostatin). Hearn PR; Reynolds CL; Johansen K; Woodhouse NJ Clin Endocrinol (Oxf); 1988 Feb; 28(2):181-5. PubMed ID: 2844445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]